336
Views
8
CrossRef citations to date
0
Altmetric
Brief Communication

Refractory hypotension due to Rogaine® (minoxidil) ingestion managed with midodrine

, , &
Pages 907-909 | Received 09 Aug 2011, Accepted 15 Sep 2011, Published online: 11 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bashir Chakar, Mark Salter & Darren M. Roberts. (2023) Minoxidil overdose with hypotension effectively managed with norepinephrine, rather than dopamine. Clinical Toxicology 61:2, pages 133-134.
Read now

Articles from other publishers (7)

Elizabeth Shanahan, Christopher Mitchell, Richard Chen & Steven Walsh. (2023) Ingestion of minoxidil associated with elevated transaminases in the absence of ischemic hepatitis. Translational Medicine Reports 6:1.
Crossref
Federico Matías Álvarez Vilariño, Issac Cheong & Raúl Alejandro Gómez. (2023) The value of speckle tracking echocardiography in diagnosing minoxidil-induced cardiotoxicity: a case report. Journal of Ultrasound.
Crossref
Tyler E. Johnson, Meghan E. Fick, Jenica L. Haraschak, Mara E. Vernier & Saki Kadotani. (2023) Successful management of minoxidil 5% toxicosis in 2 cats from the same household. Journal of Veterinary Emergency and Critical Care 33:4, pages 454-459.
Crossref
Beatrice Drambarean, Paula Bielnicka & Ali Alobaidi. (2019) Midodrine treatment in a patient with treprostinil-induced hypotension receiving hemodialysis. American Journal of Health-System Pharmacy 76:1, pages 13-16.
Crossref
Tyler J. M. Jordan, Page E. Yaxley, Christine A. Culler & Anusha Balakrishnan. (2018) Successful management of minoxidil toxicosis in a dog. Journal of the American Veterinary Medical Association 252:2, pages 222-226.
Crossref
Isabelle Claudet, Caroline Cortey, Raphaele Honorat & Nicolas Franchitto. (2015) Minoxidil Topical Solution. Pediatric Emergency Care 31:1, pages 44-46.
Crossref
Jamie J. Coleman & Anthony R. Cox. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 363 385 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.